Text Size

Application of Digital Infrared Thermal Imaging (DITI) in Graves' Disease

This study is currently recruiting participants.
Verified December 2010 by National Taiwan University Hospital
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01182584
First received: August 12, 2010
Last updated: December 21, 2010
Last verified: December 2010
History of Changes
  Purpose

Graves' disease is characterized by thyrotoxicosis, goiter, ophthalmopathy and dermopathy. Pathogenesis involves autoimmune process. The investigators think temperatures of the area involved in the inflammation may change. Thus the investigators plan to take temperature pictures of Graves' patients using digital infrared thermal imaging system and observe the change.


Condition
Graves' Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Application of Digital Infrared Thermal Imaging in Thyroid Disease and Associated Ophthalmopathy and Dermopathy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 200
Study Start Date: December 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Graves' disease
Healthy volunteers

Detailed Description:

We will recruited patients of Graves' disease from out patient clinics. We will perform thyroid echo and soft tissue echo first. Then we let patients sit before the thermal camera and take thermal images of eyes necks and tibia. After data collection, we analyse the relation between temperature and laboratory data such as thyroid function and autoimmune profiles.

  Eligibility

Ages Eligible for Study:   16 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Graves' disease patients with or without ophthalmopathy and dermopathy

Criteria

Inclusion Criteria:

  • Graves' disease patients. Healthy people

Exclusion Criteria:

  • Pregnancy. <16 years old or > 60 years old
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01182584

Contacts
Contact: Shyang-Rong Shih, M.D. 0972653337 srshih@ntu.edu.tw

Locations
Taiwan
National Taiwan University Recruiting
Taipei, Taiwan
Contact: Shyang-Rong Shih, M.D.     0972653337     srshih@ntu.edu.tw    
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Shyang-Rong Shih National Taiwan University
  More Information

No publications provided

Responsible Party: National Taiwan university
ClinicalTrials.gov Identifier: NCT01182584     History of Changes
Other Study ID Numbers: 200811040R
Study First Received: August 12, 2010
Last Updated: December 21, 2010
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Graves Disease
Exophthalmos
Orbital Diseases
Eye Diseases
Goiter
 Thyroid Diseases
Endocrine System Diseases
Hyperthyroidism
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on October 17, 2012